Characterization of the Hexanitrate Esters of Sugar Alcohols

Total Page:16

File Type:pdf, Size:1020Kb

Characterization of the Hexanitrate Esters of Sugar Alcohols Full Paper DOI: 10.1002/prep.202000197 Characterization of the Hexanitrate Esters of Sugar Alcohols Lindsay McLennan,[a] Audreyana Brown-Nash,[a] Taylor Busby,[a] Jeffrey Canaria,[a] Athina Kominia,[a] James L. Smith,[a] Jimmie C. Oxley,*[a] Faina Dubnikov,[b] Ronnie Kosloff,[b] and Yehuda Zeiri[c] Abstract: The hexanitrates of the six-carbon sugars man- ray diffraction (XRD) and Raman spectroscopy; however, no nitol and sorbitol were prepared and studied to gain in- differences were observed in the thermal behavior. Sorbitol sight in their relative stabilities. Synthesis and character- hexanitrate (SHN) has two distinct crystalline polymorphs ization of these materials resulted in the identification of that result in different melting behavior and differences in two new crystalline polymorphs, one for each hexanitrate. Raman and XRD. Thermal stability of these hexanitrates was Mannitol hexanitrate (MHN) exposed to elevated temper- also examined; despite being isomers, SHN and MHN differ atures exhibited a different structure when measured by x- in their long-term thermal stability. Keywords: Polymorphs · Nitrate ester · Sugar nitrates · thermal stability 1 Introduction Although its crystal structure was recently reported, xylitol pentanitrate (XPN) is notoriously difficult to isolate as a sol- Nitrate esters are formed from materials containing hydrox- id [14–16]. Mannitol hexanitrate (MHN) was first prepared in yl groups. Materials with multiple hydroxyl groups, polyols, 1847 by Italian scientist Ascanoio Sobrero, who had isolated have been nitrated to produce explosive compounds, NG a year earlier. Since it was solid at room temperature, which are used in both the commercial and military sectors. Sobrero was initially more interested in the potential of Some examples of common nitrate esters include pentaery- MHN rather than NG; however, following the accidental ex- thritol tetranitrate (PETN), ethylene glycol dinitrate (EGDN), plosion in his lab of 400 grams of MHN, his interest and nitroglycerin (NG) [1]. PETN is used in detonators, deto- waned.[17] MHN was used in detonators and even ex- nating cord, sheet explosives, and boosters and is even plosive rivet composition during World War II, before being found in medicinal devices. EGDN and NG found immediate replaced by more stable compositions [18]. Like NG and use in dynamite formulations and remain in many propel- PETN, MHN acts as a vasodilator and in the past has been lants, smokeless powders, and medicinal devices. Other pol- used in the treatment of angina pectoris [19]. Recently, a yols have also been subject to nitration, but due to certain co-crystal of MHN with 1-nitronaphthalene was reported; it undesirable properties, have not found military use. Polyols, had slightly decreased sensitivity but also poorer perform- such as erythritol, mannitol, and sorbitol, are referred to as ance [20]. Sorbitol hexanitrate (SHN) was reported in a 1930 sugar alcohols. They are available in the food industry as al- patent as oil that when purified, resulted in a solid ternative low-calorie sweeteners. Originally inaccessible be- (m.p. 54–55 °C) [21]. Like EGDN, SHN was considered for use cause their isolation from natural sources was expensive, bi- in non-freezing dynamites [17]. Recent nitrate ester studies oengineering found means to produce these sugars on a have examined the stereoisomers of ETN (L-ETN and D-ETN, large, efficient scale, making them accessible to the general comparing them to diastereomeric ETN) and the hexani- public [2]. Unfortunately, their widespread availability, com- trates SHN and MHN to determine if overall sensitivity (as bined with the ease of nitration makes these potential pre- judged by drop weight impact) varied among otherwise cursors for terrorist exploitation. identical molecules [22]. The discovery of nitrate esters shown in Figure 1 dates to the mid- to late-1800’s. Recently erythritol tetranitrate (ETN) has received considerable attention [3–11]. ETN has a [a] L. McLennan, A. Brown-Nash, T. Busby, J. Canaria, A. Kominia, similar explosive performance to PETN; albeit at the cost of J. L. Smith, J. C. Oxley increased sensitivity [12]. It melts significantly lower than Chemistry Department, University of Rhode Island PETN (ETN, m.p.=61 °C, PETN m.p.=141 °C, dec). This melt 140 Flagg Road, Kingston, RI 02881 is not accompanied by apparent decomposition, suggesting *e-mail: [email protected] [b] F. Dubnikov, R. Kosloff it might be melt castable. The wide commercial availability Hebrew University Jerusalem of erythritol and the low melting point of its nitrate ester [c] Y. Zeiri explains its use as a homemade explosive (HME) [13]. Ben Gurion University The nitrate esters derived from xylitol, mannitol, and Supporting information for this article is available on the WWW sorbitol have not received as much recent attention as ETN. under https://doi.org/10.1002/prep.202000197 Propellants Explos. Pyrotech. 2021, 46, 1–15 © 2021 Wiley-VCH GmbH 1 These are not the final page numbers! �� Full Paper L. McLennan et al. Figure 1. Nitrate ester explosives and their melting points. Nitrate esters as a class of improvised explosives is not chilled to 0 °C. White fuming nitric acid (10.6 mL, 0.254 mol) new, but rather its popularity is driven by the availability of was slowly added so that the temperature did not rise the precursor sugar alcohols. In the United States, the wide above 10 °C. The mixture was stirred for 30 minutes before availability of erythritol combined with the favorable prop- the polyol (2 g, 0.011 mol) was added. The addition of poly- erties of ETN has directed nitrate ester research. Xylitol, ol caused a slight temperature increase before the temper- mannitol, and sorbitol are less common but can be easily ature re-equilibrated to 0 °C. The reaction mixture was stir- purchased online in powder form. While there has been re- red at 0 °C for 2 hours and then at room temperature for searching into the mass spectrometry and thermal analysis another 2 hours. The reaction mixture was then poured into of these compounds, there is still a lack of characterization 400 mL of rapidly stirring ice water to recover the product. of these compounds. This work aims to bridge that gap In the case of MHN, and sometimes with SHN, a solid pre- with material characterization on both an experimental and cipitate formed directly from the reaction mixture. This sol- theoretical scale. id was recovered via vacuum filtration and rinsed with wa- ter, saturated aqueous sodium bicarbonate, and again with water to remove any excess acid. The solid was dried under 2 Experimental Methods vacuum for 30 minutes and then at room temperature overnight. 2.1 Synthesis of MHN Via Mixed Acid Method MHN was prepared via mixed acid nitration according to 2.3 Purification and Crystallization of SHN published literature procedures [23,24]. Fuming nitric acid was chilled in an ice bath and mannitol was slowly added, SHN did not always crystallize out when the crude reaction maintaining a temperature less than 10 °C. The resultant was poured into water. When SHN formed oily masses yellowish slurry was warmed to between 10–15 °C and sul- which hardened rather than forming a suspended solid in furic acid was slowly added. The mixture became a nearly the water, it was recovered via a modified literature proce- solid slurry and manual stirring was used to mix the re- dure [25]. The SHN was dissolved in methylene chloride and action. After an hour, the reaction was poured onto ice wa- transferred to a separatory funnel where it was washed ter, and the product recovered by vacuum filtration. The three times with water, followed by three times with satu- solid was rinsed with water, saturated sodium bicarbonate, rated sodium bicarbonate solution. The product solution and additional water to remove leftover acid impurities. The was dried over anhydrous sodium sulfate and the meth- solid dried on a vacuum for a minimum of 30 minutes and ylene chloride was evaporated under reduced pressure. The then at room temperature overnight. SHN was collected as a clear oil that was re-dissolved in minimal methylene chloride and chilled in an ice bath. Hex- ane was added slowly which resulted in a white precipitate. 2.2 Synthesis of Hexanitrate Esters Via Acetyl Nitrate The SHN was collected by vacuum filtration, rinsed with a Method small amount of cold hexane, and dried on a vacuum for 20 minutes. The final product collected was a fluffy white solid Acetic acid (21 mL, 0.367 mol) and acid anhydride (21 mL, (m.p. 53–55 °C). 0.222 mol) were placed in a 100 mL round bottom flask and 2 www.pep.wiley-vch.de © 2021 Wiley-VCH GmbH Propellants Explos. Pyrotech. 2021, 46, 1–15 �� These are not the final page numbers! Characterization of the Hexanitrate Esters of Sugar Alcohols 2.4 Synthesis of Mannitol Pentanitrate (MPN) for a total run time of 7 min. Electrospray (ESI) in negative ionization mode was used for all MHN and SHN adducts de- MPN was synthesized via a slightly modified literature pro- tections; all relevant Exactive Orbitrap conditions are pro- cedure [26]. Mannitol hexanitrate was dissolved in acetone vided in Table 1. and 0.5 mL of aqueous ammonium carbonate (0.2 g/mL) Of the expected ions ([MÀ H]À , [M+Cl]À , [M+CHOO]À À solution was added. Almost immediately the solution and [M+CH3COO] ) the chloride and formate adducts were turned orange. The solution was allowed to stand at room the predominate ones found in the analysis of MHN/SHN temperature overnight before the solvent was removed at and their lesser nitrated counterparts (i.e. mannitol pentani- reduced pressure. The resulting dark orange oil was recon- trate and sorbitol pentanitrate, MPN and SPN, and the cor- stituted in ethanol.
Recommended publications
  • Tolerance and Resistance to Organic Nitrates in Human Blood Vessels
    \ö-\2- Tolerance and Resistance to Organic Nitrates in Human Blood Vessels Peter Radford Sage MBBS, FRACP Thesis submit.ted for the degree of Doctor of Philosuphy Department of Medicine University of Adelaide and Cardiology Unit The Queen Elizabeth Hospital I Table of Gontents Summary vii Declaration x Acknowledgments xi Abbreviations xil Publications xtil. l.INTRODUCTION l.L Historical Perspective I i.2 Chemical Structure and Available Preparations I 1.3 Cellular/biochemical mechanism of action 2 1.3.1 What is the pharmacologically active moiety? 3 1.3.2 How i.s the active moiety formed? i 4 1.3.3 Which enzyme system(s) is involved in nitrate bioconversi<¡n? 5 1.3.4 What is the role of sulphydryl groups in nitrate action? 9 1.3.5 Cellular mechanism of action after release of the active moiety 11 1.4 Pharmacokinetics t2 1.5 Pharmacological Effects r5 1.5.1 Vascular effects 15 l.5.2Platelet Effects t7 1.5.3 Myocardial effects 18 1.6 Clinical Efhcacy 18 1.6.1 Stable angina pectoris 18 1.6.2 Unstable angina pectoris 2t 1.6.3 Acute myocardial infarction 2l 1.6.4 Congestive Heart Failure 23 ll 1.6.5 Other 24 1.7 Relationship with the endothelium and EDRF 24 1.7.1 EDRF and the endothelium 24 1.7.2 Nitrate-endothelium interactions 2l 1.8 Factors limiting nitrate efficacy' Nitrate tolerance 28 1.8.1 Historical notes 28 1.8.2 Clinical evidence for nitrate tolerance 29 1.8.3 True/cellular nitrate tolerance 31 1.8.3.1 Previous studies 31 | .8.3.2 Postulated mechanisms of true/cellular tolerance JJ 1.8.3.2.1 The "sulphydryl depletion" hypothesis JJ 1.8.3.2.2 Desensitization of guanylate cyclase 35 1 8.i.?..3 Impaired nitrate bioconversion 36 1.8.3.2.4'Ihe "superoxide hypothesis" 38 I.8.3.2.5 Other possible mechanisms 42 1.8.4 Pseudotolerance ; 42 1.8.4.
    [Show full text]
  • Nitric Oxide Releasing Chelating Agents and Their
    Europäisches Patentamt *EP001060174B1* (19) European Patent Office Office européen des brevets (11) EP 1 060 174 B1 (12) EUROPEAN PATENT SPECIFICATION (45) Date of publication and mention (51) Int Cl.7: C07D 401/12, A61K 31/44 of the grant of the patent: 22.09.2004 Bulletin 2004/39 (86) International application number: PCT/GB1998/003840 (21) Application number: 98962567.8 (87) International publication number: (22) Date of filing: 18.12.1998 WO 1999/033823 (08.07.1999 Gazette 1999/27) (54) NITRIC OXIDE RELEASING CHELATING AGENTS AND THEIR THERAPEUTIC USE STICKSTOFFOXID FREISETZENDE CHELATBILDNER UND IHRE THERAPEUTISCHE VERWENDUNG CHELATEURS LIBERANT DE L’OXYDE NITRIQUE ET LEUR EMPLOI A DES FINS THERAPEUTIQUES (84) Designated Contracting States: (74) Representative: AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU Hammett, Audrey Grace Campbell et al MC NL PT SE Amersham plc Amersham Place (30) Priority: 23.12.1997 GB 9727226 Little Chalfont, Bucks. HP7 9NA (GB) 13.03.1998 GB 9805450 (56) References cited: (43) Date of publication of application: EP-A- 0 292 761 WO-A-93/20806 20.12.2000 Bulletin 2000/51 WO-A-95/12394 WO-A-96/31217 WO-A-96/39409 WO-A-97/49390 (73) Proprietor: Amersham Health AS US-A- 5 250 550 0401 Oslo (NO) • MOORADIAN D L ET AL: "NITRIC OXIDE (NO) (72) Inventors: DONOR MOLECULES: EFFECT OF NO • TOWART, Robertson RELEASE RATE ON VASCULAR SMOOTH Stoke Poges SL2 4PT (GB) MUSCLE CELL PROLIFERATION IN VITRO" • KARLSSON, Jan, Olof, Gustav JOURNAL OF CARDIOVASCULAR N-1450 Nesoddtangen (NO) PHARMACOLOGY, vol.
    [Show full text]
  • Potentially Explosive Chemicals*
    Potentially Explosive Chemicals* Chemical Name CAS # Not 1,1’-Diazoaminonaphthalene Assigned 1,1-Dinitroethane 000600-40-8 1,2,4-Butanetriol trinitrate 006659-60-5 1,2-Diazidoethane 000629-13-0 1,3,5-trimethyl-2,4,6-trinitrobenzene 000602-96-0 1,3-Diazopropane 005239-06-5 Not 1,3-Dinitro-4,5-dinitrosobenzene Assigned Not 1,3-dinitro-5,5-dimethyl hydantoin Assigned Not 1,4-Dinitro-1,1,4,4-tetramethylolbutanetetranitrate Assigned Not 1,7-Octadiene-3,5-Diyne-1,8-Dimethoxy-9-Octadecynoic acid Assigned 1,8 –dihydroxy 2,4,5,7-tetranitroanthraquinone 000517-92-0 Not 1,9-Dinitroxy pentamethylene-2,4,6,8-tetramine Assigned 1-Bromo-3-nitrobenzene 000585-79-5 Not 2,2',4,4',6,6'-Hexanitro-3,3'-dihydroxyazobenzene Assigned 2,2-di-(4,4,-di-tert-butylperoxycyclohexyl)propane 001705-60-8 2,2-Dinitrostilbene 006275-02-1 2,3,4,6- tetranitrophenol 000641-16-7 Not 2,3,4,6-tetranitrophenyl methyl nitramine Assigned Not 2,3,4,6-tetranitrophenyl nitramine Assigned Not 2,3,5,6- tetranitroso nitrobenzene Assigned Not 2,3,5,6- tetranitroso-1,4-dinitrobenzene Assigned 2,4,6-Trinitro-1,3,5-triazo benzene 029306-57-8 Not 2,4,6-trinitro-1,3-diazabenzene Assigned Not 2,4,6-Trinitrophenyl trimethylol methyl nitramine trinitrate Assigned Not 2,4,6-Trinitroso-3-methyl nitraminoanisole Assigned 2,4-Dinitro-1,3,5-trimethyl-benzene 000608-50-4 2,4-Dinitrophenylhydrazine 000119-26-6 2,4-Dinitroresorcinol 000519-44-8 2,5-dimethyl-2,5-diydroperoxy hexane 2-Nitro-2-methylpropanol nitrate 024884-69-3 3,5-Dinitrosalicylic acid 000609-99-4 Not 3-Azido-1,2-propylene glycol dinitrate
    [Show full text]
  • Pharmaceutical Appendix to the Tariff Schedule 2
    Harmonized Tariff Schedule of the United States (2007) (Rev. 2) Annotated for Statistical Reporting Purposes PHARMACEUTICAL APPENDIX TO THE HARMONIZED TARIFF SCHEDULE Harmonized Tariff Schedule of the United States (2007) (Rev. 2) Annotated for Statistical Reporting Purposes PHARMACEUTICAL APPENDIX TO THE TARIFF SCHEDULE 2 Table 1. This table enumerates products described by International Non-proprietary Names (INN) which shall be entered free of duty under general note 13 to the tariff schedule. The Chemical Abstracts Service (CAS) registry numbers also set forth in this table are included to assist in the identification of the products concerned. For purposes of the tariff schedule, any references to a product enumerated in this table includes such product by whatever name known. ABACAVIR 136470-78-5 ACIDUM LIDADRONICUM 63132-38-7 ABAFUNGIN 129639-79-8 ACIDUM SALCAPROZICUM 183990-46-7 ABAMECTIN 65195-55-3 ACIDUM SALCLOBUZICUM 387825-03-8 ABANOQUIL 90402-40-7 ACIFRAN 72420-38-3 ABAPERIDONUM 183849-43-6 ACIPIMOX 51037-30-0 ABARELIX 183552-38-7 ACITAZANOLAST 114607-46-4 ABATACEPTUM 332348-12-6 ACITEMATE 101197-99-3 ABCIXIMAB 143653-53-6 ACITRETIN 55079-83-9 ABECARNIL 111841-85-1 ACIVICIN 42228-92-2 ABETIMUSUM 167362-48-3 ACLANTATE 39633-62-0 ABIRATERONE 154229-19-3 ACLARUBICIN 57576-44-0 ABITESARTAN 137882-98-5 ACLATONIUM NAPADISILATE 55077-30-0 ABLUKAST 96566-25-5 ACODAZOLE 79152-85-5 ABRINEURINUM 178535-93-8 ACOLBIFENUM 182167-02-8 ABUNIDAZOLE 91017-58-2 ACONIAZIDE 13410-86-1 ACADESINE 2627-69-2 ACOTIAMIDUM 185106-16-5 ACAMPROSATE 77337-76-9
    [Show full text]
  • Prediction of the Crystalline Densities of Aliphatic Nitrates by Quantum Chemistry Methods
    Central European Journal of Energetic Materials ISSN 1733-7178; e-ISSN 2353-1843 Copyright © 2019 Sieć Badawcza Łukasiewicz – Institute of Industrial Organic Chemistry, Poland Cent. Eur. J. Energ. Mater. 2019, 16(3): 412-432; DOI 10.22211/cejem/112306 Article is available in PDF-format, in colour, at: http://www.wydawnictwa.ipo.waw.pl/cejem/Vol-16-Number3-2019/CEJEM_00978.pdf Article is available under the Creative Commons Attribution-Noncommercial-NoDerivs 3.0 license CC BY-NC-ND 3.0. Research paper Prediction of the Crystalline Densities of Aliphatic Nitrates by Quantum Chemistry Methods Guixiang Wang,* Yimin Xu, Chuang Xue, Zhiyuan Ding, Yan Liu, Hui Liu, Xuedong Gong** Computation Institute for Molecules and Materials, Department of Chemistry, Nanjing University of Science and Technology, Nanjing 210094, China E-mails: * [email protected]; ** [email protected] Abstract: Crystal density is a basic and important parameter for predicting the detonation performance of explosives, and nitrate esters are a type of compound widely used in the military context. In this study, thirty-one aliphatic nitrates were investigated using the density functional theory method (B3LYP) in combination with six basis sets (3-21G, 6-31G, 6-31G*, 6-31G**, 6-311G* and 6-31+G**) and the semiempirical molecular orbital method (PM3). Based on the geometric optimizations at various theoretical levels, the molecular volumes and densities were calculated. Compared with the available experimental data, the densities calculated by various methods are all overestimated, and the errors of the PM3 and B3LYP/3-21G methods are larger than those of other methods. Considering the results and the computer resources required by the calculations, the B3LYP/6-31G* method is recommended for predicting the crystalline densities of organic nitrates using a fitting equation.
    [Show full text]
  • Compositions Comprising Nebivolol
    (19) TZZ ZZ__T (11) EP 2 808 015 A1 (12) EUROPEAN PATENT APPLICATION (43) Date of publication: (51) Int Cl.: 03.12.2014 Bulletin 2014/49 A61K 31/34 (2006.01) A61K 31/502 (2006.01) A61K 31/353 (2006.01) A61P 9/00 (2006.01) (21) Application number: 14002458.9 (22) Date of filing: 16.11.2005 (84) Designated Contracting States: • O’Donnell, John AT BE BG CH CY CZ DE DK EE ES FI FR GB GR Morgantown, WV 26505 (US) HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI • Bottini, Peter Bruce SK TR Morgantown, WV 26505 (US) • Mason, Preston (30) Priority: 31.05.2005 US 141235 Morgantown, WV 26504 (US) 10.11.2005 US 272562 • Shaw, Andrew Preston 15.11.2005 US 273992 Morgantown, WV 26504 (US) (62) Document number(s) of the earlier application(s) in (74) Representative: Samson & Partner accordance with Art. 76 EPC: Widenmayerstraße 5 09015249.7 / 2 174 658 80538 München (DE) 05848185.4 / 1 890 691 Remarks: (71) Applicant: MYLAN LABORATORIES, INC This application was filed on 16-07-2014 as a Morgantown, NV 26504 (US) divisional application to the application mentioned under INID code 62. (72) Inventors: • Davis, Eric Morgantown, WV 26508 (US) (54) Compositions comprising nebivolol (57) The active ingredients of the pharmaceutical composition described consist of nebivolol, one or more ACE inhibitors and one or more ARB. EP 2 808 015 A1 Printed by Jouve, 75001 PARIS (FR) EP 2 808 015 A1 Description [0001] This application is a continuation-in-part of application Ser.
    [Show full text]
  • (12) United States Patent (10) Patent No.: US 6,391,895 B1 Towart Et Al
    USOO639 1895B1 (12) United States Patent (10) Patent No.: US 6,391,895 B1 Towart et al. (45) Date of Patent: May 21, 2002 (54) NITRICOXIDE RELEASING CHELATING FOREIGN PATENT DOCUMENTS AGENTS AND THER THERAPEUTIC USE WO O 292 761 A 11/1988 WO WO 93 20806 A 10/1993 (75) Inventors: Robertson Towart, Stoke Poges (GB); WO WO 95 12394 A 5/1995 Jan Olof Gustav Karlsson, WO WO 96 31217 A 10/1996 Nesoddtangen (NO); Lars Goran WO WO 96 394O9 A 12/1996 Wistrand; Hakan Malmgren, both of WO WO 97.49390 A 12/1997 Lund (SE) WO 97/494.09 12/1997 ................. 514/335 (73) Assignee: Amersham Health AS, Oslo (NO) OTHER PUBLICATIONS (*) Notice: Subject to any disclaimer, the term of this Mooradian D.L. et al., “Nitric Oxide (No) Donor Molecules: patent is extended or adjusted under 35 Effect of No Release Rate on Vascular Smooth Muscle Cell U.S.C. 154(b) by 0 days. Proliferation in Vitro’, Journal of Cardiovascular Pharma cology, Jan. 1, 1995, XP000563583. (21) Appl. No.: 09/599,862 Lefer D.J.: “Myocardial Protective Actions of Nitric Oxide Doors. After Myocardial Ischemia and Reperfusion”, New (22) Filed: Jun. 23, 2000 Horizons, Feb. 1, 1995, XP000575669. Related U.S. Application Data * cited by examiner (63) Continuation of application No. PCT/GB98/03804, filed on Dec. 18, 1998. Primary Examiner-Charanjit S. Aulakh (60) Provisional application No. 60/076.793, filed on Mar. 4, (74) Attorney, Agent, or Firm-Royal N. Ronning, Jr. 1998. (57) ABSTRACT (30) Foreign Application Priority Data Chelating agents, in particular dipyridoxyl and aminopoly Dec.
    [Show full text]
  • United States Patent (10) Patent No.: US 7,235,237 B2 L0scalz0 Et Al
    USOO7235237B2 (12) United States Patent (10) Patent No.: US 7,235,237 B2 L0ScalZ0 et al. (45) Date of Patent: Jun. 26, 2007 (54) METHODS OF TREATING VASCULAR 5,968,983 A 10/1999 Kaesemeyer DISEASES CHARACTERIZED BY NITRC 5,973,011 A 10/1999 Noack et al. OXIDE INSUFFICIENCY 6,103,769 A 8, 2000 Kelm 6,117,872 A 9, 2000 Maxwell et al. (75) Inventors: Joseph Loscalzo, Dover, MA (US); 6,319,515 B1 1 1/2001 Hidaka et al. Joseph A. Vita, Hingham, MA (US); 6,458,797 B1 10/2002 Adams et al. Michael D. Loberg, Boston, MA (US); 2004, OO63719 A1 4/2004 Adams et al. Manuel Worcel, Boston, MA (US) FOREIGN PATENT DOCUMENTS (73) Assignee: NitroMed, Inc., Lexington, MA (US) EP O327263 A 8, 1989 (*) Notice: Subject to any disclaimer, the term of this EP O 968 713 A1 5, 1998 patent is extended or adjusted under 35 JP O905915.2 3, 1997 U.S.C. 154(b) by 492 days. WO WO95/26725 10, 1995 WO WO 98.21 193 5, 1998 (21) Appl. No.: 10/415,136 WO WO 99.00361 1, 1999 WO WO 99,66921 12/1999 (22) PCT Filed: May 2, 2001 WO WO 99,67231 12/1999 WO WO O1/35961 A 5, 2001 (86). PCT No.: PCT/USO1A14245 OTHER PUBLICATIONS S 371 (c)(1), (2), (4) Date: Apr. 25, 2003 Dupuis, Cardiovascular Drugs and Therapy, 8(3):501-507 (1994). Cohn et al. The New England Journal of Medicine, 325(5):303-310 (87) PCT Pub.
    [Show full text]
  • Commerce in Explosives; 2020 Annual Those on the Annual List
    Federal Register / Vol. 85, No. 247 / Wednesday, December 23, 2020 / Notices 83999 inspection at the Office of the Secretary or synonyms in brackets. This list Black powder substitutes. and on EDIS.3 supersedes the List of Explosive *Blasting agents, nitro-carbo-nitrates, This action is taken under the Materials published in the Federal including non-cap sensitive slurry and authority of section 337 of the Tariff Act Register on January 2, 2020 (Docket No. water gel explosives. of 1930, as amended (19 U.S.C. 1337), 2019R–04, 85 FR 128). Blasting caps. and of §§ 201.10 and 210.8(c) of the The 2020 List of Explosive Materials Blasting gelatin. Commission’s Rules of Practice and is a comprehensive list, but is not all- Blasting powder. Procedure (19 CFR 201.10, 210.8(c)). inclusive. The definition of ‘‘explosive BTNEC [bis (trinitroethyl) carbonate]. materials’’ includes ‘‘[e]xplosives, BTNEN [bis (trinitroethyl) nitramine]. By order of the Commission. BTTN [1,2,4 butanetriol trinitrate]. Issued: December 18, 2020. blasting agents, water gels and detonators. Explosive materials, Bulk salutes. William Bishop, include, but are not limited to, all items Butyl tetryl. Supervisory Hearings and Information in the ‘List of Explosive Materials’ Officer. C provided for in § 555.23.’’ 27 CFR Calcium nitrate explosive mixture. [FR Doc. 2020–28458 Filed 12–22–20; 8:45 am] 555.11. Accordingly, the fact that an BILLING CODE 7020–02–P Cellulose hexanitrate explosive explosive material is not on the annual mixture. list does not mean that it is not within Chlorate explosive mixtures. coverage of the law if it otherwise meets DEPARTMENT OF JUSTICE Composition A and variations.
    [Show full text]
  • Characterization of Explosives & Precursors
    Appendix A: Project Reports ALERT Thrust R1: Characterization & Elimination of Illicit Explosives Phase 2 Year 7 Annual Report Project R1-A.1 R1-A.1: Characterization of Explosives & Precursors I. PARTICIPANTS INVOLVED FROM JULY 1, 2019 TO JUNE 30, 2020 Faculty/Staff Name Title Institution Email Jimmie Oxley Co-PI URI [email protected] Jim Smith Co-PI URI [email protected] Gerald Kagan Post-Doc URI [email protected] Graduate, Undergraduate and REU Students Name Degree Pursued Institution Month/Year of Graduation Taylor Busby PhD URI 5/2021 Lindsay McLennan PhD URI 5/2020 Robert Ichiyama PhD URI 5/2023 II. PROJECT DESCRIPTION A. Project Overview This project sought to determine the physical properties, synthesis, and destruction mechanisms of improvised explosives, often called homemade explosives (HMEs). In Year 7, we performed further characterization on erythritol tetranitrate (ETN) and on the nitro-sugars mannitol and sorbitol hexanitrate and HMTD. For ETN, we examined its synthesis and sought stable isotope signatures that might allow attribution to particular groups. For the sugars we are attempting to establish basic properties and observing different polymorphs. The existence of polymorphs was also found with HMTD. B. State of the Art and Technical Approach Stable isotope analysis is a technique capable of determining the subtle differences between the stable isotope ratios of hydrogen (2H/1H), carbon (13C/12C), nitrogen (15N/14N), oxygen (18O/16O), and, with special modifications, sulfur (34S/32S). Stable isotope analyses are important for provenance studies, where minute differences in isotope ratios can determine production location. Stable isotope ratio mass spectrometry (IRMS) has been considered as a forensic science technique for attribution that has been applied to illicit drugs, chemical weapon agents, and recently to explosives.
    [Show full text]
  • Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DIX to the HTSUS—Continued
    20558 Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DEPARMENT OF THE TREASURY Services, U.S. Customs Service, 1301 TABLE 1.ÐPHARMACEUTICAL APPEN- Constitution Avenue NW, Washington, DIX TO THE HTSUSÐContinued Customs Service D.C. 20229 at (202) 927±1060. CAS No. Pharmaceutical [T.D. 95±33] Dated: April 14, 1995. 52±78±8 ..................... NORETHANDROLONE. A. W. Tennant, 52±86±8 ..................... HALOPERIDOL. Pharmaceutical Tables 1 and 3 of the Director, Office of Laboratories and Scientific 52±88±0 ..................... ATROPINE METHONITRATE. HTSUS 52±90±4 ..................... CYSTEINE. Services. 53±03±2 ..................... PREDNISONE. 53±06±5 ..................... CORTISONE. AGENCY: Customs Service, Department TABLE 1.ÐPHARMACEUTICAL 53±10±1 ..................... HYDROXYDIONE SODIUM SUCCI- of the Treasury. NATE. APPENDIX TO THE HTSUS 53±16±7 ..................... ESTRONE. ACTION: Listing of the products found in 53±18±9 ..................... BIETASERPINE. Table 1 and Table 3 of the CAS No. Pharmaceutical 53±19±0 ..................... MITOTANE. 53±31±6 ..................... MEDIBAZINE. Pharmaceutical Appendix to the N/A ............................. ACTAGARDIN. 53±33±8 ..................... PARAMETHASONE. Harmonized Tariff Schedule of the N/A ............................. ARDACIN. 53±34±9 ..................... FLUPREDNISOLONE. N/A ............................. BICIROMAB. 53±39±4 ..................... OXANDROLONE. United States of America in Chemical N/A ............................. CELUCLORAL. 53±43±0
    [Show full text]
  • Federal Register/Vol. 79, No. 194/Tuesday, October 7, 2014
    60496 Federal Register / Vol. 79, No. 194 / Tuesday, October 7, 2014 / Notices Commission rules 210.21(a)(2), (b)(1). DEPARTMENT OF JUSTICE are regulated explosive materials The ALJ also found that there is no regardless of their size or specific indication that termination of the Bureau of Alcohol, Tobacco, Firearms, energetic composition. The addition of investigation in view of the settlement and Explosives this term will not expand the list to agreement would have an adverse [Docket No. 2014R–25T] include any materials not already impact on the public interest. No party covered under other names. ATF petitioned for review of the ID. The Commerce in Explosives; 2014 Annual generally classifies pyrotechnic fuse as Commission has determined not to List of Explosive Materials low explosives subject to the Federal explosives laws and implementing review the ID and has terminated the AGENCY: Bureau of Alcohol, Tobacco, investigation. explosives regulations at 27 CFR Part Firearms, and Explosives (ATF); 555—Commerce in Explosives and the The authority for the Commission’s Department of Justice. U.S. Department of Transportation determination is contained in section ACTION: Notice of list of explosive classifies them as Class 1 explosives. 337 of the Tariff Act of 1930, as materials. External burning pyrotechnic fuses that amended, 19 U.S.C. 1337, and in Part are components of small arms 210 of the Commission’s Rules of SUMMARY: Pursuant to 18 U.S.C. 841(d) ammunition will remain exempt Practice and Procedure, 19 CFR part and 27 CFR 555.23, the Department pursuant to 18 U.S.C.
    [Show full text]